BIOMAT Database Logo BIOMAT Database Logo

Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis. 2017

Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
1 Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt.

Neuron-specific enolase is a sensitive marker of neuronal damage in various neurologic disorders. This study aimed to measure serum neuron-specific enolase levels at different time points and severities of diabetic ketoacidosis. This study included 90 children (age 9.2 ± 3.4 years) with diabetic ketoacidosis. Neuron-specific enolase was measured at 3 time points (baseline and after 12 and 24 hours of starting treatment). Among patients, 74.4% had diagnosis of new diabetes, 60% had Glasgow Coma Scale score <15, and 75.6% had moderate/severe diabetic ketoacidosis. Compared with controls (n = 30), children with diabetic ketoacidosis had higher neuron-specific enolase levels at the 3 time points ( P = .0001). In multiple regression analysis, the factors associated with higher neuron-specific enolase levels were younger age, higher glucose, lower pH, and bicarbonate values. This study indicates that serum neuron-specific enolase is elevated in diabetic ketoacidosis and correlated with the severity of hyperglycemia, ketosis, and acidosis. This study indicates that diabetic ketoacidosis may cause neuronal injury from which the patients recovered partially but not completely.

UI MeSH Term Description Entries
D008297 Male Males
D010751 Phosphopyruvate Hydratase A hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity. Enolase,Neuron-Specific Enolase,2-Phospho-D-Glycerate Hydro-Lyase,2-Phospho-D-Glycerate Hydrolase,2-Phosphoglycerate Dehydratase,Enolase 2,Enolase 3,Muscle-Specific Enolase,Nervous System-Specific Enolase,Non-Neuronal Enolase,alpha-Enolase,beta-Enolase,gamma-Enolase,2 Phospho D Glycerate Hydro Lyase,2 Phospho D Glycerate Hydrolase,2 Phosphoglycerate Dehydratase,Dehydratase, 2-Phosphoglycerate,Enolase, Muscle-Specific,Enolase, Nervous System-Specific,Enolase, Neuron-Specific,Enolase, Non-Neuronal,Hydratase, Phosphopyruvate,Hydro-Lyase, 2-Phospho-D-Glycerate,Muscle Specific Enolase,Nervous System Specific Enolase,Neuron Specific Enolase,Non Neuronal Enolase,System-Specific Enolase, Nervous,alpha Enolase,beta Enolase,gamma Enolase
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis
November 2019, Journal of clinical research in pediatric endocrinology,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Serum neuron-specific enolase levels after subarachnoid hemorrhage.
September 1991, Surgical neurology,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
October 1984, Cancer,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Elevated serum levels of neuron specific enolase in lymphoid leukaemia.
January 1990, Leukemia & lymphoma,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Does cardiopulmonary bypass change serum neuron-specific enolase levels?
December 2007, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
[Dynamic changes in serum neuron-specific enolase levels in neonates].
November 2014, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Studies of neuron-specific enolase levels in serum and cerebrospinal fluid of children with neurological diseases.
March 1990, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
Serum neuron-specific enolase levels in lung pathologies. Our experience.
January 1987, The International journal of biological markers,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
[Changes of serum neuron-specific enolase and serum ferritin levels in patients with pneumoconiosis].
July 2013, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases,
Sherifa Hamed, and Kotb Abbass Metwalley, and Hekma Saad Farghaly, and Tahra Sherief
[Significance of serum neuron-specific enolase levels after head injury].
November 1993, No shinkei geka. Neurological surgery,
Copied contents to your clipboard!